These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 19208562)
21. Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease. Omori S; Hida M; Fujita H; Takahashi H; Tanimura S; Kohno M; Awazu M J Am Soc Nephrol; 2006 Jun; 17(6):1604-14. PubMed ID: 16641154 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of p38 mitogen-activated protein kinase pathway as prophylaxis of postoperative ileus in mice. Wehner S; Straesser S; Vilz TO; Pantelis D; Sielecki T; de la Cruz VF; Hirner A; Kalff JC Gastroenterology; 2009 Feb; 136(2):619-29. PubMed ID: 19014943 [TBL] [Abstract][Full Text] [Related]
23. Activation of p38 mitogen-activated protein kinase in spinal microglia contributes to incision-induced mechanical allodynia. Wen YR; Suter MR; Ji RR; Yeh GC; Wu YS; Wang KC; Kohno T; Sun WZ; Wang CC Anesthesiology; 2009 Jan; 110(1):155-65. PubMed ID: 19104183 [TBL] [Abstract][Full Text] [Related]
24. Apoptosis induction by p38 MAPK inhibitor in human colon cancer cells. Tsuchiya T; Tsuno NH; Asakage M; Yamada J; Yoneyama S; Okaji Y; Sasaki S; Kitayama J; Osada T; Takahashi K; Nagawa H Hepatogastroenterology; 2008; 55(84):930-5. PubMed ID: 18705300 [TBL] [Abstract][Full Text] [Related]
25. Role of p38 mitogen-activated protein kinase on cardiac dysfunction after hemorrhagic shock in rats. Sato H; Tanaka T; Kasai K; Kita T; Tanaka N Shock; 2007 Sep; 28(3):291-9. PubMed ID: 17545949 [TBL] [Abstract][Full Text] [Related]
26. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice. Sadanaga A; Nakashima H; Akahoshi M; Masutani K; Miyake K; Igawa T; Sugiyama N; Niiro H; Harada M Arthritis Rheum; 2007 May; 56(5):1618-28. PubMed ID: 17469144 [TBL] [Abstract][Full Text] [Related]
27. Infiltrating dendritic cells contribute to local synthesis of C1q in murine and human lupus nephritis. Castellano G; Trouw LA; Fiore N; Daha MR; Schena FP; van Kooten C Mol Immunol; 2010 Jul; 47(11-12):2129-37. PubMed ID: 20417969 [TBL] [Abstract][Full Text] [Related]
28. Attenuation of autoimmune disease in Fas-deficient mice by treatment with a cytotoxic benzodiazepine. Bednarski JJ; Warner RE; Rao T; Leonetti F; Yung R; Richardson BC; Johnson KJ; Ellman JA; Opipari AW; Glick GD Arthritis Rheum; 2003 Mar; 48(3):757-66. PubMed ID: 12632430 [TBL] [Abstract][Full Text] [Related]
29. Abrogation of skin disease in LUPUS-prone MRL/FASlpr mice by means of a novel tylophorine analog. Choi JY; Gao W; Odegard J; Shiah HS; Kashgarian M; McNiff JM; Baker DC; Cheng YC; Craft J Arthritis Rheum; 2006 Oct; 54(10):3277-83. PubMed ID: 17009262 [TBL] [Abstract][Full Text] [Related]
30. Noradrenaline reduces the ATP-stimulated phosphorylation of p38 MAP kinase via beta-adrenergic receptors-cAMP-protein kinase A-dependent mechanism in cultured rat spinal microglia. Morioka N; Tanabe H; Inoue A; Dohi T; Nakata Y Neurochem Int; 2009 Sep; 55(4):226-34. PubMed ID: 19524113 [TBL] [Abstract][Full Text] [Related]
31. Lack of FGF-1 overexpression during autoimmune nephritis in the kidneys of MRL lpr/lpr mice. Madiai F; Hackshaw KV Res Commun Mol Pathol Pharmacol; 1999 Jan; 103(1):37-44. PubMed ID: 10440569 [TBL] [Abstract][Full Text] [Related]
32. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice. Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294 [TBL] [Abstract][Full Text] [Related]
33. Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus. Zeller GC; Hirahashi J; Schwarting A; Sharpe AH; Kelley VR J Am Soc Nephrol; 2006 Jan; 17(1):122-30. PubMed ID: 16291836 [TBL] [Abstract][Full Text] [Related]
34. Protective effects of FR167653 on chronic allograft nephropathy by inhibiting p38 MAPK in rats. Tan HB; Feng Y; Liu M; Wu YC Transplant Proc; 2008 Jun; 40(5):1685-9. PubMed ID: 18589173 [TBL] [Abstract][Full Text] [Related]
35. JNK1/c-Jun and p38 alpha MAPK/ATF-2 pathways are responsible for upregulation of Fas/FasL in human chronic myeloid leukemia K562 cells upon exposure to Taiwan cobra phospholipase A2. Chen KC; Chiou YL; Chang LS J Cell Biochem; 2009 Oct; 108(3):612-20. PubMed ID: 19670268 [TBL] [Abstract][Full Text] [Related]
37. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice. Hasegawa H; Kohno M; Sasaki M; Inoue A; Ito MR; Terada M; Hieshima K; Maruyama H; Miyazaki J; Yoshie O; Nose M; Fujita S Arthritis Rheum; 2003 Sep; 48(9):2555-66. PubMed ID: 13130475 [TBL] [Abstract][Full Text] [Related]
38. Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2. Lu LD; Stump KL; Wallace NH; Dobrzanski P; Serdikoff C; Gingrich DE; Dugan BJ; Angeles TS; Albom MS; Mason JL; Ator MA; Dorsey BD; Ruggeri BA; Seavey MM J Immunol; 2011 Oct; 187(7):3840-53. PubMed ID: 21880982 [TBL] [Abstract][Full Text] [Related]
39. Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation. Conrad DM; Furlong SJ; Doucette CD; Boudreau RT; Hoskin DW Cell Signal; 2009 Aug; 21(8):1298-307. PubMed ID: 19324083 [TBL] [Abstract][Full Text] [Related]
40. High mobility group box protein-1 in experimental autoimmune uveoretinitis. Watanabe T; Keino H; Sato Y; Kudo A; Kawakami H; Okada AA Invest Ophthalmol Vis Sci; 2009 May; 50(5):2283-90. PubMed ID: 19151394 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]